GlaxoSmithKline neglected to report to regulatory authorities that there
was a statistically significant increased risk of sudden infant death
in the four days after administration of its hexavalent vaccine A 2017 commentary by India-based physicians Jacob Puliyel and C. Sathyamala in the Indian Journal of Medical Ethics
describes a shocking dereliction of duty on the part of regulators who
were presented with vaccine data carefully tailored to obscure serious
risks. Tackling concerns about infant deaths that have occurred
following hexavalent vaccination in several European countries, the
authors of the commentary show that GlaxoSmithKline (GSK) neglected to
report to regulatory authorities that there was a statistically
significant increased risk of sudden infant death in the four days after
administration of its hexavalent vaccine—and the regulatory agency in
question (the EMA) ignored the omission and accepted GSK’s apparently
whitewashed data at face value. Read More |
Tuesday, September 18, 2018
Infant Deaths Following Vaccination: The Numbers Don’t Lie—Or Do They?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment